H.C. Wainwright & Co., LLC , a leading investment bank focused on capital markets, equity research and sales & trading in growth industries, including the Healthcare and Life Sciences sectors, announced that Richard E. Gormley has joined the Firm as Vice Chairman and President of Capital Markets.

“We are excited to have Richard join H.C. Wainwright and we welcome him to the team,” said Mark Viklund, Chief Executive Officer of H.C. Wainwright. “In 2018, H.C. Wainwright completed over 145 transactions to date, representing over $6.5 billion in transaction value. Richard joins H.C. Wainwright at a juncture where we have built significant momentum in executing some of the most prominent healthcare financings completed in recent years. His breadth of experience and outstanding reputation in the equity and equity-linked capital markets will enable us to enhance our growth trajectory.”

Gormley commented, “I have known H.C. Wainwright’s team members and respected their leadership position in investment banking for many years. I am delighted to join H.C. Wainwright and contribute to its future growth and success as we build a dominant franchise in providing investment banking services to the Healthcare, Life Sciences and other growth sectors.”

Gormley has over 30 years of experience in the investment banking and capital markets business, having completed over $30 billion of public and private financing and corporate finance transactions. Most recently, he was a Senior Managing Director and Head of Equity Capital Markets of Guggenheim Securities. Prior to Guggenheim, he was a Vice Chairman of Lazard Freres, where he led the firm’s Alternative Capital Finance business. He has also held executive leadership positions in the capital markets businesses at SG Cowen & Company and Rabobank International. Gormley began his investment banking career at Citibank and BMO Nesbitt Burns Securities.